GlaxoSmithKline has sold a plant in India once used to make the recalled heartburn drug Zantac for only a fraction of its initial cost.…
A federal judge has cleared the way for direct filing in Zantac lawsuits through the use of an expedited Short Form Complaint.…
Plaintiffs have filed two amended class action lawsuits in Zantac cancer litigation, seeking for manufacturers to pay for economic losses and medical monitoring for those who took the recalled heartburn drug.…
Two new studies appear to strengthen the science indicating Zantac’s active ingredient, ranitidine, converts to the cancer-causing chemical NDMA duriing digestive processes.…
Parties involved in valsartan cancer lawsuits have put forward 28 potential early test cases to serve as bellwether trials to represent at least 600 claims the recalled hypertension drugs contained high levels of NDMA.…
A federal judge has cleared the way for valsartan NDMA lawsuits to proceed against manufacturers of the tainted hypertension drugs.…
Another Nostrum generic metformin recall expansion was announced after the company again found high levels of NDMA in the diabetes drugs.…
Plaintiffs involved in 41 federal Zantac lawsuits say their cases were wrongly removed to federal court, and are asking the Zantac MDL judge to remand their cases back to California state courts where they originated.…
Plaintiffs say they plan to show how numerous types of cancer are linked to the side effects of Zantac, which has been recalled due to high levels of the toxic chemical, NDMA.…
A previous metformin recall has been expanded after high levels of NDMA were detected in an additional lot of the diabetes drug tablets.…
